Contribute Try STAT+ Today

An experimental gene therapy that turns a patient’s own blood cells into cancer killers worked in a major study, with more than one-third of very sick lymphoma patients showing no sign of disease six months after a single treatment, its maker said Tuesday.

In all, 82 percent of patients had their cancer shrink at least by half at some point in the study.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • Good news. I am 9 months cancer free after participating in the Juno CAR 17 trial for relapsed NHL. My chemo induced peripheral neuropathy has gotten much worse. Do you have any evidence from Kite relative to patients who started their trial with my problem and how their CIPN has been affected. I can not get any response from Juno when I tell City of Hope how bad my pain and leg and hand cramping has become. Keep the info coming. I talk to lots of patients at COH who have no idea these clinical trials are out there. Steve Kohn-San Diego

    • Steve, my son participated in JUNO’s CART-15 trial. Because of the neuropathy side effect he was unable to walk. But the doctor prescribed the right physical therapy for him and it helped a lot. email me for details at [email protected]

Comments are closed.